Enterprise Value
-25.22M
Cash
118.5M
Avg Qtr Burn
-23.13M
Short % of Float
2.74%
Insider Ownership
7.82%
Institutional Own.
60.69%
Qtr Updated
06/30/23
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
REL-1017 Details Major depressive disorder, Mental health | Phase 3 Data readout |